Department of Ophthalmology, University of Ottawa, The Ottawa Hospital, the Ottawa Hospital Research Institute, Ottawa, Ont; Department of Pathology, University of Ottawa, The Ottawa Hospital, the Ottawa Hospital Research Institute, Ottawa, Ont..
Department of Ophthalmology, University of Ottawa, The Ottawa Hospital, the Ottawa Hospital Research Institute, Ottawa, Ont; Department of Pathology, University of Ottawa, The Ottawa Hospital, the Ottawa Hospital Research Institute, Ottawa, Ont.
Can J Ophthalmol. 2018 Apr;53(2):155-161. doi: 10.1016/j.jcjo.2017.07.025. Epub 2017 Oct 9.
There is a gap in the recent literature on the topic of clinically misdiagnosed and unsuspected posterior uveal melanomas (PUM) with a calculation of the frequency of these events for a specific geographical area. As the only ophthalmic pathology laboratory in our region, we determined the rate of these outcomes over a 16-year period.
We retrospectively reviewed 2558 consecutive ophthalmic pathologic specimens in the Ottawa-Gatineau region, of which 334 were eviscerations and 227 were enucleations. We calculated the frequency of clinically misdiagnosed PUM and of clinically unsuspected PUM. We also determined the rate of uveal melanoma undergoing enucleation.
From 100 diagnoses of PUM, 2 (2.0%) cases were clinically unsuspected and 2 (2.0%) cases were clinically misdiagnosed. The rate of uveal melanoma undergoing enucleation was 5.6 cases per 1 000 000 of population per annum. From 2009 to 2012, the incidence of this event was 3.8 cases per 1 000 000 per annum, which was lower than the previous three 4-year increments.
We present the first and only single-centred, population-based data on the rates of unsuspected PUM and of clinical misdiagnosis of PUM in the era of modern diagnostic imaging. Our rate of clinical misdiagnosis is within the range of recent reports of this event. Unsuspected PUM occurred at a rate substantially lower than previously published. The incidence of uveal melanoma undergoing enucleation has decreased despite an increase in population, which reflects a shift in management from enucleation to radiation therapy.
近期关于临床误诊和未被怀疑的后葡萄膜黑色素瘤(PUM)的文献存在空白,缺乏针对特定地理区域这些事件频率的计算。由于我们是该地区唯一的眼科病理学实验室,我们确定了在 16 年内发生这些结果的概率。
我们回顾性分析了渥太华-加蒂诺地区 2558 例连续的眼科病理标本,其中 334 例是眼内容剜除术,227 例是眼球摘除术。我们计算了临床误诊 PUM 和临床未被怀疑的 PUM 的频率。我们还确定了接受眼球摘除术的葡萄膜黑色素瘤的比率。
从 100 例 PUM 诊断中,有 2 例(2.0%)为临床未被怀疑,2 例(2.0%)为临床误诊。每年每 100 万人中有 5.6 例葡萄膜黑色素瘤接受眼球摘除术。从 2009 年到 2012 年,这一事件的发生率为每年每 100 万人 3.8 例,低于之前三个 4 年递增的水平。
我们首次提供了唯一的基于人群的单中心数据,涉及现代诊断成像时代未被怀疑的 PUM 和 PUM 的临床误诊率。我们的临床误诊率处于最近关于这一事件的报告范围内。未被怀疑的 PUM 的发生率明显低于之前的报道。尽管人口增加,但接受眼球摘除术的葡萄膜黑色素瘤的发病率下降,这反映了从眼球摘除术向放射治疗的治疗方式转变。